Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Prostate
|
February 11, 1999
Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2
A C Gao, W Lou, T Ichikawa, et al.
Oncogene
|
March 17, 2015
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells
D J Barakat, J Zhang, T Barberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells
C Jackisch, H A Hahm, B Tombal, et al.
Journal of Medicinal Chemistry
|
December 14, 2001
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells
C M Jakobsen, S R Denmeade, J T Isaacs, et al.
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1997
Apoptosis in hormone-responsive malignancies
S R Denmeade, D E McCloskey, I B Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells
A T Weeraratna, S L Dalrymple, J C Lamb, et al.
Oncogene
|
June 22, 2010
Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response
M B Weiss, M I Vitolo, M Mohseni, et al.
Prostate Cancer and Prostatic Diseases
|
October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
C J Paller, D Olatoye, S Xie, et al.
Scientific Reports
|
July 22, 2021
Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors
O C Rogers, D M Rosen, L Antony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
J L Gala, S Loric, Y Guiot, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Prostate
|
February 11, 1999
Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2
A C Gao, W Lou, T Ichikawa, et al.
Oncogene
|
March 17, 2015
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells
D J Barakat, J Zhang, T Barberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells
C Jackisch, H A Hahm, B Tombal, et al.
Journal of Medicinal Chemistry
|
December 14, 2001
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells
C M Jakobsen, S R Denmeade, J T Isaacs, et al.
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1997
Apoptosis in hormone-responsive malignancies
S R Denmeade, D E McCloskey, I B Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells
A T Weeraratna, S L Dalrymple, J C Lamb, et al.
Oncogene
|
June 22, 2010
Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response
M B Weiss, M I Vitolo, M Mohseni, et al.
Prostate Cancer and Prostatic Diseases
|
October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
C J Paller, D Olatoye, S Xie, et al.
Scientific Reports
|
July 22, 2021
Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors
O C Rogers, D M Rosen, L Antony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
J L Gala, S Loric, Y Guiot, et al.
Page
of 4